General MedicationsTOPICALStandard
TAZAROTENE
TAZAROTENE
Standard Dose
0.1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TAZAROTENE is listed in Drugs@FDA under application 214136 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TAZAROTENE Form and strength GEL;TOPICAL - 0.1% Sponsor COSETTE Submission history Latest submission status date: 2022-09-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview TAZAROTENE is listed in Drugs@FDA under application 214136 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TAZAROTENE Form and strength GEL;TOPICAL - 0.1% Sponsor COSETTE Submission history Latest submission status date: 2022-09-13 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.